Apr 2024 $5 M No. 4 $2 to $10 million 3
Flagship Biosciences, Inc.: Raise no. 4, Apr 2024 × Investors in this round 3 investors had bought by the notice of Apr 18, 2024: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $6 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Tom Turi · Executive Officer, Director Trevor Johnson · Executive Officer, Director Herb Hooper · Director Paul Kirchgraber · Director William Snider · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Trevor Johnson, Ceo. Source: SEC Form D, newest notice filed Apr 18, 2024. Read the notice at the SEC .
equity SEC Nov 2023 $3 M No. 3 $2 to $10 million 3
Flagship Biosciences, Inc.: Raise no. 3, Nov 2023 × Investors in this round 3 investors had bought by the notice of Feb 21, 2024: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible Promissory Notes Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Trevor Johnson · Executive Officer, Director Herb Hooper · Director Paul Kirchgraber · Director Tom Turi · Director William Snider · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Trevor Johnson, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Feb 21, 2024. Read the notice at the SEC .
debt, options SEC Aug 2022 $15 M Issued in a merger or acquisition $10 to $50 million 3
Flagship Biosciences, Inc.: Private sale, Aug 2022 × Investors in this round 3 investors had bought by the notice of Sep 9, 2022: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Trevor Johnson · Executive Officer, Director Bill H. Snider · Director Fisher Aaron · Director Herb H. Hooper · Director Tom H. Turi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Trevor Johnson, CEO and President. Source: SEC Form D, newest notice filed Sep 9, 2022. Read the notice at the SEC .
equity SEC Jun 2018 $3 M No. 2 $2 to $10 million 10
Flagship Biosciences, Inc.: Raise no. 2, Jun 2018 × Investors in this round 10 investors had bought by the notice of Jul 9, 2018: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice G. David Young · Executive Officer, Director, Promoter Holger Dean Lange · Executive Officer Joe Dean Kruger · Executive Officer L. Dean Northey · Executive Officer Trevor Johnson · Executive Officer, Director, Promoter Gary Dean Clark · Director Nancy Dean Gillett · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by L. Dean Northey, CFO, Secretary, Treasurer. Source: SEC Form D, newest notice filed Jul 9, 2018. Read the notice at the SEC .
equity SEC Jan 2018 $1 M No. 1 Under $2 million 9
Flagship Biosciences, Inc.: Raise no. 1, Jan 2018 × Investors in this round 9 investors had bought by the notice of Mar 16, 2018: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Dean David Northey · Executive Officer G. David Young · Executive Officer, Director, Promoter Trevor Johnson · Executive Officer, Director, Promoter Gary M. Clark · Director Gregory K. Tucker · Director Nancy A. Gillett · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds of the offering shall be maintained in a separate bank account. Some of the proceeds may be used for general working capital purposes which may include payment of salaries, expenses and fees to those listed in Item 3.”Signed by Dean Northey, Chief Financial Officer, Secretary,Treasurer. Source: SEC Form D, newest notice filed Mar 16, 2018. Read the notice at the SEC .
debt, options SEC